Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARTIVION, INC.CRY · Entity 4767 | SVP, CHRO | March 14, 2019 | March 18, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARTIVION, INC.
Report date March 14, 2019 · Filed March 18, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,806 |
Ending reported balance
After 2019-03-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-03-14 · Grant · Acquired 4,948 · Balance 31,551 F1: Represents performance stock units granted on March 12, 2018 and earned at approximately 80% of target based on 2018 adjusted EBITDA. Fifty percent (50%) were issued on March 14, 2018. The remaining shares earned in connection with the March 2018 grant will vest and be issued as follows: 50% on 03/12/2020, and 50% on 03/12/2021, assuming continued employment on the relevant vesting date. Row 2 · 2019-03-14 · Tax withholding · Disposed 745 · Balance 30,806 F2: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents performance stock units granted on March 12, 2018 and earned at approximately 80% of target based on 2018 adjusted EBITDA. Fifty percent (50%) were issued on March 14, 2018. The remaining shares earned in connection with the March 2018 grant will vest and be issued as follows: 50% on 03/12/2020, and 50% on 03/12/2021, assuming continued employment on the relevant vesting date.
F2: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2019 Filed Mar 18, 2019 21:01 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 745 | $29.82 | $22,215.90 |
DisclosureSEC source: 0000784199-19-000090 · certent-form4.xml · nonDerivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,806 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 21:01 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,948 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000090 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,551 F1 · shares: Represents performance stock units granted on March 12, 2018 and earned at approximately 80% of target based on 2018 adjusted EBITDA. Fifty percent (50%) were issued on March 14, 2018. The remaining shares earned in connection with the March 2018 grant will vest and be issued as follows: 50% on 03/12/2020, and 50% on 03/12/2021, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:45 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantStock Option (Right to Buy) · Derivative | 11,625 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000052 · certent-form4.xml · derivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,625 Underlying: Common Stock · 11,625 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:45 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000052 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,603 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:22 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 501 | $29.70 | $14,879.70 |
DisclosureSEC source: 0000784199-19-000044 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,102 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| December 31, 2018 Filed Feb 19, 2019 12:47 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionStock Option (Right to Buy) · Derivative | 89 | $23.67 Strike: $23.67 | $2,106.85 |
DisclosureSEC source: 0000784199-19-000006 · certent-form5.xml · derivative · entry 3 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89 shares Expires 2018-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2018 Filed Feb 19, 2019 12:47 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionCommon Stock | 89 | $23.67 | $2,106.85 |
DisclosureSEC source: 0000784199-19-000006 · certent-form5.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. F2 · balance_after: In a Form 4 filed on July 10, 2018, Reporting Person over reported the total number of shares beneficially owned by a de minimus number of shares. As a result, such shares were reflected in the post-transaction amounts in column 5 of that Form 4. Beneficially owned shares are hereby updated in column 5 on this Form 5 to remove such previously-added shares. Read SEC document |
| July 01, 2018 Filed Feb 19, 2019 12:47 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantStock Option (Right to Buy) · Derivative | 89 | $23.67 Strike: $23.67 | $2,106.85 |
DisclosureSEC source: 0000784199-19-000006 · certent-form5.xml · derivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89 Underlying: Common Stock · 89 shares Expires 2018-12-31 Read SEC document |
| June 30, 2018 Filed Jul 10, 2018 20:47 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionESPP · Derivative | 1,179 | $16.24 Strike: $16.24 | $19,141.07 |
DisclosureSEC source: 0000784199-18-000145 · certent-form4.xml · derivative · entry 3 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,179 shares Expires 2018-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:52 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantStock Option (Right to Buy) · Derivative | 15,910 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-18-000075 · certent-form4.xml · derivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,910 Underlying: Common Stock · 15,910 shares Expires 2025-03-12 Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:52 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 6,187 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000075 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,339 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 997 | $19.15 | $19,092.55 |
DisclosureSEC source: 0000784199-18-000052 · certent-form4.xml · nonDerivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,152 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 5,652 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000052 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,149 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:47 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantESPP · Derivative | 1,179 | $16.24 Strike: $16.24 | $19,141.07 |
DisclosureSEC source: 0000784199-18-000145 · certent-form4.xml · derivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,179 Underlying: Common Stock · 1,179 shares Expires 2018-06-30 Read SEC document |
| January 01, 2018 Filed Jul 10, 2018 20:47 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionCommon Stock | 1,179 | $16.24 | $19,141.07 |
DisclosureSEC source: 0000784199-18-000145 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 21:47 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionStock Option (Right to Buy) · Derivative | 821 | $16.28 Strike: $16.28 | $13,363.83 |
DisclosureSEC source: 0000784199-18-000006 · certent-form5.xml · derivative · entry 3 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 821 shares Expires 2017-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 21:47 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantStock Option (Right to Buy) · Derivative | 821 | $16.28 Strike: $16.28 | $13,363.83 |
DisclosureSEC source: 0000784199-18-000006 · certent-form5.xml · derivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 821 Underlying: Common Stock · 821 shares Expires 2017-12-31 Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 21:47 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionCommon Stock | 821 | $16.28 | $13,363.83 |
DisclosureSEC source: 0000784199-18-000006 · certent-form5.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 00:03 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 6,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000025 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,676 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.